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Abstract
Background: Improving our understanding of the immune response is fundamental to developing strategies to
combat a wide range of diseases. We describe an integrated epitope analysis system which is based on principal
component analysis of sequences of amino acids, using a multilayer perceptron neural net to conduct QSAR
regression predictions for peptide binding affinities to 35 MHC-I and 14 MHC-II alleles.
Results: The approach described allows rapid processing of single proteins, entire proteomes or subsets thereof, as
well as multiple strains of the same organism. It enables consideration of the interface of diversity of both
microorganisms and of host immunogenetics. Patterns of binding affinity are linked to topological features, such as
extracellular or intramembrane location, and integrated into a graphical display which facilitates conceptual
understanding of the interplay of B-cell and T-cell mediated immunity.
Patterns which emerge from application of this approach include the correlations between peptides showing
high affinity binding to MHC-I and to MHC-II, and also with predicted B-cell epitopes. These are characterized as
coincident epitope groups (CEGs). Also evident are long range patterns across proteins which identify regions of
high affinity binding for a permuted population of diverse and heterozygous HLA alleles, as well as subtle
differences in reactions with MHCs of individual HLA alleles, which may be important in disease susceptibility, and
in vaccine and clinical trial design. Comparisons are shown of predicted epitope mapping derived from application
of the QSAR approach with experimentally derived epitope maps from a diverse multi-species dataset, from
Staphylococcus aureus, and from vaccinia virus.
Conclusions: A desktop application with interactive graphic capability is shown to be a useful platform for
development of prediction and visualization tools for epitope mapping at scales ranging from individual proteins
to proteomes from multiple strains of an organism. The possible functional implications of the patterns of peptide
epitopes observed are discussed, including their implications for B-cell and T-cell cooperation and cross
presentation.
Background
The availability of proteomic information is increasing
exponentially. This is especially true for pathogenic
microorganisms. Integration and interpretation of vast
amounts of data from the analysis of proteomic infor-
mation, so that it may be useful to bench scientists and
clinicians is a growing challenge. Achieving this goal is
essential if bioinformatic analysis is to lead to improved
vaccines and antibody therapies and to a better
understanding of patient and population responses to
infections, cancers, autoimmune epitopes, and allergens.
Experimental approaches to definition of epitopes are
time consuming and expensive; predictive methods can
provide maps which could reduce the effort needed in
experimental characterization.
Current Challenges in Epitope Analysis
In reviewing approaches to epitope characterization
described in the literature, both experimentally and
through the use of computer-based analysis, three broad
shortcomings become apparent. * Correspondence: robert_bremel@iogenetics.com
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epitope characterization have often been narrow in
scope, based on the response of individual patients, cells
from a few individual donors or single strains of mice,
or focused on isolated peptides. This has generated valid
data, but which is specific to the narrow set of circum-
stances and not reflective of the broader host or organ-
ism population. Discovering binding affinity for an
MHC molecule of a single HLA haplotype will not
necessarily be predictive for a population of diverse het-
erozygotic individuals. Many literature reports claim T-
cell epitope characterization but fail to report the MHC
restriction (mouse) or HLA of cells used. By limiting
consideration to isolated peptides, an important feature
of cell biology is overlooked. Binding to MHC-I and
MHC-II molecules is a competitive and dynamic process
[1,2]. MHC molecules bind to peptides selected from
among all those competitors which result from the pro-
teolysis of the whole organism. Predictive determina-
tions of preferential epitope binding can thus only be
made when considered in the context of the whole pro-
teome, or, at very least, the whole protein, but not for
isolated peptides.
Second, from an epidemiologic perspective the out-
come of infection is dependent on the interface between
a population of heterozygous hosts and a diverse array
of microbial strains. Many possible interactions of indi-
vidual and strain are possible. Depending on the con-
text, the challenge in vaccine design may be to choose
the best combination of epitopes conserved across mul-
tiple strains of an organism to protect an entire immu-
nogenetically diverse community (for infectious
diseases), or to select the immunostimulant optimal for
a specific patient (in cancer immunotherapeutics).
Third, while there is broad recognition that strong
T-cell responses are essential to good memory, and in
many cases to effective immunity, efforts to characterize
B-cell and T-cell responses have not always been well
integrated.
B-cell and T-cell cooperative interaction in antigen
presentation has been the subject of many landmark
papers [3-6]. More recently, Sette et al demonstrated
that, at least for vaccinia, T-cell stimulation is specific to
a B-cell epitope located within the same protein [7],
pointing to a close determinant association between B-
cell and T-cell epitopes. Cross reactivity, or polyspecifi-
city, is a necessary feature of the T-cell recognition of
epitopes comprised of MHC-peptide complexes [8,9].
There has been increasing recognition that, both for
anti-infective immunity, and for cancer immunity, dis-
tinctions between the role of MHC-I and MHC-II in
responding to intra or extra-cellular organisms are not
clear cut [10-13]. MHC-II molecules bind longer pep-
tides (15-20 amino acids) whereas MHC-I molecules
bind shorter peptides of ~9 amino acids or less [1].
Binding of MHC molecules to peptides is characterized
by a large degree of degeneracy and it is now recognized
that a particular MHC molecule may bind peptides that
vary widely in composition and origin [9].
B-cell epitopes may be continuous or discontinuous
peptides, in some cases requiring multiple linear pep-
tides to be configured together to make up a complete
epitope [14]. Location of B-cell epitope motifs in loops
external to the cell membrane may allow for grouping
into a multi-component epitope. Multiple peptides may
need to act together to provide an immunostimulant
adequate to initiate a B-cell response. Batista has
described the need for B-cells to have sufficient stimula-
tion to form immune synapses, initiating and enabling
the uptake of surface proteins [15]. In other cases B-cell
responses occur independent of T cell stimulation [16].
Most successful antimicrobial vaccines target surface
exposed B-cell epitopes and vaccines have been evalu-
ated by their ability to stimulate an antibody response.
Peptide epitopes are a major component of the overall
epitope complex, or immunome, and are genetically spe-
cified. In many cases antibodies to bacterial proteins are
indeed protective, and complement fixing antibodies
have been used as an index of vaccinal efficacy [17].
Immunization protocols for laboratory production of
antibodies have long recognized the utility to linkage to
a known T-cell epitope [18,19]. T-cell responses to epi-
topes arrayed in an organism of interest are harder to
evaluate [20]. Those working in reverse vaccinology [21]
have been frustrated by the difficulty of reliably charac-
terizing T-cell epitopes [17]. Proteins with multiple
transmembrane domains have proven challenging to
express as sub-unit vaccines [21]. In understanding the
interaction of B-cell and T-cell responses, it is therefore
useful to readily understand the topology of epitopes
relative to the cell membrane. In the case of immu-
notherapeutic cancer vaccines, the ability to stimulate a
multifaceted T-cell response may be even more neces-
sary [22,23].
State of the Art: Epitope prediction programs
Various bioinformatic programs for B-cell epitope and
T-cell epitope analysis are available on the Internet
(Additional File 1) and have contributed significantly to
our understanding. However, a number of limitations
are evident. Limits on the sequence size which can be
submitted to website servers generally only allows single
protein analysis and thus preclude contextual under-
standing of competitive binding affinity for a whole
proteome.
B-cell epitope predictions
Schemes for prediction of B-cell epitopes have been
available for nearly 30 years. Hopp and Woods [24] first
Bremel and Homan Immunome Research 2010, 6:8
http://www.immunome-research.com/content/6/1/8
Page 2 of 21proposed the use of amino acid sequences to identify
the most immunogenic regions in proteins and recog-
nized the relative importance of surface exposure, a con-
cept furthered by Parker et al [25]. By using various
l e n g t h so fp e p t i d e sa si n d i c e st op r o d u c es c o r i n g
metrics, about 70% of the epitopes in a small set of pro-
teins could be accurately predicted. A wide array of
methods has been published since, but the predictive
performance has not greatly improved [26]. The field
has recently been critically reviewed by Davydov and
Tenevitsky [27], who use a preferred binary classification
metric AROC method of evaluation. Recalculated, the
accuracy reported by Hopp and Wood and the contem-
porary AROC values are not substantially different.
The availability of the BepiPred program over the
Internet (on the servers at the Center for Biological
Sequence Analysis (CBS)), and its ability to process par-
tial proteome-scale sequence data, led us to initially uti-
lize this program [28]. Interestingly, the algorithms rely
heavily on the work of Parker [25]. We subsequently
found that the amino acid principal components NN
regression approach, which we describe in the accompa-
nying paper [29], and which uses the physical property
data sets of Hopp and Woods [30], Parker et al [25],
and others, could produce outputs indistinguishable
from BepiPred [28]. This enabled us to consolidate the
computations into a single platform along with MHC
binding predictions and facilitated integration with
genomic data processing programs.
MHC binding Predictions
DeGroot reviews T-cell epitope mapping systems avail-
able publically and developed commercially [31]. Many
T-cell epitope prediction programs depend on substitu-
tion matrix scoring of individual amino acids. As we
have discussed in a companion paper [29], this does not
provide a complete physicochemical description of the
binding relationship. Substitution matrices are the back-
bone of bioinformatics, but were originally developed to
assist in understanding evolutionary genetic relation-
ships, not physicochemical properties. Quantitative
structure activity relationship (QSAR) approaches that
utilize the physicochemical properties of interacting
species as a foundation are a more appropriate method.
These have been applied by one group but in the con-
text of peptides rather than proteins or proteomes
[32-36].
The bioinformatic approaches currently available and
discussed above are designed to analyze B-cell epitopes
or T-cell epitopes but, despite the recognized interplay
of B and T cells, fail to integrate the two to provide a
complete picture of the immunome.
Virtually all website based programs understandably
place limits on sequence size. Further complicating this
is the absence of uniformity in size limitations, making
consistent data manipulation challenging. The outputs
are difficult to integrate when obtained piecemeal. More
importantly, from a practical viewpoint, software relia-
bility testing over the internet is at best challenging.
Where the programs can be acquired for local use, the
Unix/Linux platforms favored by the bioinformatics
community are not commonly available in laboratory
settings so converting the programs into functional uti-
lity in a local setting is not trivial.
Our first goal was thus to produce a unified system,
that consolidated the various immunological metrics
into one set of tools and operated within the context of
commercially available software on widely-used comput-
ing platforms. MHC-I and MHC-II binding using the
neural network and partial least squared platforms of
JMP® (also JMP® Genomics) http://www.jmp.com is
described in an accompanying paper [29]. Secondly, we
recognized the need to examine the interface of immu-
nogenetically diverse patient populations along with an
array of different strains of the same organism. Thirdly,
we considered a graphical display that allowed visualiza-
tion of the output of very complex statistical com-
putations to be desirable. Our conceptual model in
approaching this third goal was the superior level of
understanding of land use provided by geographic infor-
mation systems (GIS) which overlay multiple informa-
tion sets of physical and economic geography. We have
applied this concept to the microbial surfome “land-
scape”. In this paper we describe an integrated bioinfor-
matics analysis system which we believe approaches
these goals.
Methods
Selection of Benchmark Datasets
We sought appropriate benchmark datasets to test the
system developed. None were available which provided
comparable levels of information on all the features we
sought to integrate. While a useful repository, the IEDB
tabulation of individual epitopes is less useful for pro-
teomic-scale work. We selected three datasets for com-
parison. The “AntiJen” database provided a benchmark
for evaluating a diverse repository of epitopes within the
context of entire protein molecules. Two well studied
infectious organisms, Staphylococcus aureus and vaccinia
virus, enabled retrospective comparisons with published
data.
AntiJen
We examined reference datasets of mapped B-cell epi-
topes on various websites. Additions or subtractions of
sequences have been made to some datasets (reviewed
in Davydov [27]). We sought datasets where epitopes
had been mapped for the entire length of a protein and
which provided a wide array of source proteins. We
downloaded the datasets of identified B-cell epitopes
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is a derivative of that described by Toseland et al [37]
(but no longer available at the weblink provided in this
publication). From the annotations, some of the proteins
appear to trace to the time of Hopp and Woods [24].
This dataset may be accessible from other websites but
we report herein our use of it as downloaded from CBS
[38,39] (currently accessible at http://www.cbs.dtu.dk/
suppl/immunology/Bepipred.php).
As downloaded, the “AntiJen” data set comprised 124
proteins spanning mammalian, viral, protozoan, bacter-
ial, and other origins (Additional File 2, Table S2a), in
which 246 B-cell epitopes have been defined experimen-
tally by various labs and various methods. Larsen et al
state that “the proteins of this data set are not fully
annotated, and the annotation for the non-epitope
stretches is not known” [28].
Staphylococcus aureus
Many experimental studies have been conducted to
define epitopes on several proteins of Staph. aureus (See
Additional File 3, Table S3a). Proteomes of multiple
strains are available in Genbank. We worked with the
15 strains listed in Additional File 3, Table S3b.
Vaccinia
In view of the detailed experimental epitope mapping
information available for vaccinia [11,40-42] and the
demonstration by Sette et al [7] of the deterministic
linkage of B-cell and T-cell epitopes at a protein level in
the I1L core protein of vaccinia, we also processed the
vaccinia proteome, and report on the results for a subset
of four proteins as an illustration of the use of the inte-
grated system to provide predicted HLA-specific differ-
ences in binding affinity.
Process Description
A system for integrated analysis of proteome scale epi-
tope information was designed which comprises a num-
ber of sub-processes. All computations were done and
graphics generated using JMP® version 8 http://www.jmp.
com. Figure 1 provides an overview of the system; the
sub-processes are described briefly below and in detail in
Additional File 4.
Process A consists of developing a set of Neural Net-
work (NN) binding predictions for 14 MHC-II and 35
MHC-I molecules. Once developed these equations are
stored for further use. Briefly, principal component amino
acid analysis was carried out on the physical properties of
amino acids measured in a total of thirty-one different pub-
lished studies. In the NN each amino acid is assigned 3
numerical values based its principal components rather
than the standard alphabetical representation commonly
used in bioinformatics. This type of descriptor is
commonly used in QSAR analysis where it is known as the
“z"-scale [43,44]. The principal component descriptors are
uncorrelated, mutually orthogonal metrics, and embody
about 90% of the variance in all physical properties of the
20 amino acids commonly found in proteins. The z-scales
are not in themselves physical properties, but rather uncor-
related dimensionless proxies for amino acid physical prop-
erties that can be used predictively: z1 is a hydrophobicity
or polarity correlate, z2 a size correlate and z3 an electronic
correlate. A characteristic of principal component analysis
is that it also produces a set of descriptors that are appro-
priately weighted for regression analysis. This process is
described in detail in a companion paper where it is bench-
marked against several other prediction schemes [29].
Process B, also described in the companion paper,
consists of replacing the alphabetic notation of amino
acids by z-scales so that each 9-mer in the proteome is
represented as a vector of 27 numbers and each 15-mer
as a vector of 45 numbers. These numerical values are
then used to compute predicted binding affinities for
peptides in the proteome using the NN prediction equa-
tions from Process A.
Process C involves the use of one of several publicly
available programs for protein topology predictions. We
have variously used PHOBIUS [45], PHILIUS [46],
MEMSAT [47], and TMH [48]. The output is a probabil-
ity prediction for each amino acid in the protein as being
intracellular, extracellular, within a membrane or a signal
peptide. A determination of B-cell epitope predictions is
also made. Unlike the MHC predictions which provide a
predicted affinity, in the case of B-cell epitopes we are
making a binary “yes-no” probability prediction that a
specific amino acid lies in a B-cell epitope. The B-cell
epitope probability may be achieved by submission to
one of several publicly available programs for B-cell epi-
tope predictions [28], however we generated a B-cell epi-
tope prediction based on principal components, enabling
us to achieve this step as an integral part of the process.
Process D i n t e g r a t e st h eo u t p u tf r o mt h ef i r s tt h r e e
processes and involves the use of self-organizing mapping
algorithms to identify Coincident Epitope Groups (CEG)
for protein segments likely to be accessible to the immune
system. CEGs are peptides in which high affinity MHC
binding peptides and B cell epitopes are found to overlap
or whose borders lie within a user-specifiable distance of
each other. As described herein the distance was set at
3 amino acids.
Process E is a database task to assemble nearly identical
protein sets (NIPS) from different strains of organisms to
arrive at a minimalist set of conserved or near-conserved
peptide epitopes for further consideration.
Standardization
To facilitate further statistical procedures, the MHC
binding affinities (as natural logarithms) were standar-
dized. Standardization is a common statistical process
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and unit variance (and standard deviation as the stan-
dard deviation is the square root of the variance). Thus
all binding affinities of all different supertypes, and
paired supertype combinations, were put on the same
basis for further computations. This process is reversible
s ot h a tam o r ee x p e r i m e n t a l l ym e a n i n g f u li c 50 can be
obtained at any point if desired. Secondly, the Bayesian
probabilities for each individual amino acid being in a
B-cell epitope were subjected to global standardization
like that for the MHC binding affinities. Thus, all the
peptides and other metrics subject to statistical screen-
ing are standardized, so that thresholding or other selec-
tions are made on single or joint normal probability
distributions.
Following the standardization processes, the tables of
binding affinities contained columns of the original pre-
dicted binding affinity data for the different MHC super-
types (as natural logarithms) and the original B-cell
epitope probabilities, as well as corresponding columns
of standardized (zero mean, unit standard deviation)
data of the immunologically relevant endpoints.
Design of Graphical Output
Visualization of all epitope components in relation to
topology facilitates understanding of function. A graphi-
cal scheme (Step 13 in Figure 1) was developed that
made it possible to readily visualize the topology of pro-
teins at the surface of the organism as well as three
standardized probabilities for high affinity binding
Figure 1 Elements of peptide epitope prediction process.
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tions for MHC-I and MHC-II binding were done routi-
nely for all organisms, although it is recognized that
MHC-I is generally considered most relevant for intra-
cellular infectious organisms and MHC-II for extracellu-
lar organisms. Simultaneous visualization of both
provides a method of conceptualization of potential
cross-presentation of epitopes.
We adopted a convention for graphical display in
which the amino acids positions are aligned along the X
a x i sf r o mNt oC .T h eYa x i si si ns t a n d a r d i z e du n i t s
(zero mean, unit std dev) to show MHC binding affinity.
Topological information is displayed in the background
shading. The permuted minima ln(ic50) representing the
mean population phenotype are plotted for MHC-I and/
or MHC-II at each peptide position the number repre-
senting a mean of 105 (MHC-II) or 630 (MHC-I) allelic
combinations at that position. This is windowed average
minima ± 4 amino acids from the plotted point. A
smooth line fit through the points is produced using the
polynomial filter of Savists k ya n dG o l a y[ 4 9 ] .A n o t h e r
line is overlaid to show the standardized probability of
B-cell epitope binding. Across the base of the graphic
we use ribbons of various colors and intensities to desig-
nate regions of high binding affinity and coincidence of
B-cell and MHC binding. Different thresholding strin-
gencies can be applied to the ribbons (see Additional
F i l e5 ) ;w eh a v em o s t l yf o u n dt h a tt h e2 5
th percentile
of the permuted minimum distribution of MHC bind-
ing along with the 25
th percentile of B-cell epitope
p r o b a b i l i t yt ob eu s e f u lt h r e s h o l d sa n dt h e s ea r eu s e d
throughout the graphics below. The 25
th percentile
should be clearly understood to be a threshold from
within the permuted minima distributions that have
their own mean and standard deviations, and not the
25
th percentile of all peptides. Colored vertical lines are
used to show the behavior of any particular HLA allele
as compared to the permuted population phenotype.
The line extends from the permuted population value to
the standardized value of the indicated HLA at the N-
terminus of the peptide 9-mer or 15-mer. By creating a
further overlay experimentally defined epitopes can be
compared with predictions. The display can easily be
rescaled to visualize the individual amino acids in the
peptides.
Results
Observations of Single Proteomes
Table 1 is summary of the binding affinities for
MHC-II supertypes for the surfome (surface proteome)
and secretome (secreted proteins) of Staphylococcus
aureus COL (Genbank genome accession number =
NC_002951). The surfome consists of all proteins coded
for in the genome that have a molecular signature(s)
predicting their insertion in cell membranes. Some pro-
teins in the surfome also have signal peptides that con-
trol topology but do not lead to secretion.
Prediction of B-cell epitopes, MHC-II binding, and
topology for 15 strains of Staph. aureus (listed in Addi-
tional File 3, Table S3b) have been done. Predicted
Table 1 MHC-II binding affinities of all overlapping 15-mers in the surfome of Staphylococcus aureus COL NC_002951.
MHC-II
Supertype
Ave ln
(ic50)
Std Dev ln
(ic50)
10%-tile ln
(ic50)
Ave IC50
(nM)
Ave-SD ic50
(nM)
10%-tile ic50
(nM)
Ave-2SD ic50
(nM)
DRB1_0101 4.48 3.11 0.54 88.27 3.95 1.72 0.18
DRB1_0301 6.29 1.93 3.81 540.59 78.15 45.28 11.30
DRB1_0401 5.31 2.59 1.95 202.23 15.12 7.04 1.13
DRB1_0404 5.23 2.76 1.63 187.57 11.84 5.12 0.75
DRB1_0405 4.38 1.90 1.92 79.92 11.96 6.81 1.79
DRB1_0701 4.29 2.84 0.62 73.33 4.27 1.85 0.25
DRB1_0802 7.05 2.00 4.48 1151.07 155.45 88.42 20.99
DRB1_0901 5.85 2.48 2.64 346.90 29.03 13.99 2.43
DRB1_1101 5.58 2.52 2.35 265.50 21.39 10.46 1.72
DRB1_1302 7.14 1.95 4.62 1257.67 178.85 101.68 25.43
DRB1_1501 5.86 2.74 2.31 351.12 22.61 10.07 1.46
DRB3_0101 8.26 1.95 5.74 3861.57 547.81 312.37 77.71
DRB4_0101 5.69 2.20 2.81 294.70 32.68 16.67 3.62
DRB5_0101 4.92 2.60 1.58 136.76 10.12 4.85 0.75
Average 5.74 2.40 2.64 631.2 80.2 44.7 10.7
Exp(Average) nM 310.5 11.0 14.1
The surface proteome consists of all proteins that have one or more predicted transmembrane helices in their structure. The statistics were derived from
approximately 216,000 15-mers for 14 supertypes, or about 3.02 million binding predictions. The NN were trained and the predictions were made in the natural
logarithmic domain (ln). The statistical parameters are for the entire proteome, as this would constitute the population of peptides presented binding to MHC
molecules on the surface of antigen presenting cells.
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side the bacterial cell membrane, but virtually none in
the transmembrane domains, perhaps due to alpha heli-
cal structure of the transmembrane peptides. In the very
few instances where extension into membranes did
occur (<2%), the predicted B-cell epitope only pene-
trated a few amino acids. This may represent an error in
the prediction of the edge of the transmembrane
domain.
A summary of the topology of the proteins and the
predicted MHC-I and MHC-II binding affinity of pep-
tides in Staph. aureus COL is shown in Table 2. It is
recognized that the immunological response to Staph.
aureus should be mediated primarily through MHC-II;
MHC-I is included for completeness. The table shows
the relatively higher binding affinity of peptides found in
membrane spanning segments of the proteome. The dif-
ference in the ln(ic50) of the MHC-II affinities of the
intracellular and extracellular segments is small but is
statistically significant.
Interface with a Diverse Host Population
The array of genetic variants (supertypes) of HLA mole-
cules in the human population vastly exceeds that for
which there are peptide training sets. Additionally, and
yet further increasing the combinatorial possibilities, is
the fact that each individual has both parental genotypes
of MHC on their cell membranes. Despite the combina-
torial complexity, examination of the statistics of the
predicted binding affinities to a number of different pro-
teins in the proteome of Staph. aureus gave rise to sev-
eral observations which suggested that it would be
possible to derive a system for determining the probabil-
ity of binding not only for single supertypes, but for a
population of combinatorial supertypes for which a
trained NN was available. The processes outlined above
make it possible to put entire proteomes (or multiple
proteomes) consisting of millions of binding affinities
into a single data table, in a familiar spreadsheet inter-
face on a standard workstation computer.
Table 3 shows the predicted binding affinities for each
of the DRB supertypes in combination with each of the
other DRB molecules (105 permutations) simulating het-
erozygous individuals (detail in Additional File 6). Inside
an antigen presenting cell where peptides from a
digested organism (e.g. Staph. aureus COL) are coming
into contact with MHC-II molecules, those molecules
with higher affinity (smaller of the two ln affinity num-
bers) would be expected to dominate in the binding
process. One of the striking features that emerges from
this table (bottom rows Table 3) is the overall advantage
of heterozygosity. Individuals randomly inheriting com-
binational pairs of the 14 supertypes stand to have a
higher binding affinity than if they had only one type. A
second observation is the segregation of different alleles
within the sorted list. The heterozygosity advantage and
the 10 percentile threshold, being in a range considered
a useful biological range of affinity, suggested the possi-
bility of averaging over all genotypes as a means of pre-
dicting binding in a population of individuals carrying
MHC-II molecules of unknown genotype on their cells
(as would be the case in a randomly selected vaccinee
population). These results s u g g e s tt h a tc o m b i n a t o r i a l
pairs of supertypes need to be considered in statistical
selection and screening processes, for example in clinical
trials.
The different alleles and allelic combinations shown in
Table 3 have significantly different means and variance
and this complicates statistical analysis and thresholding.
All of the proteins in the Staph. aureus surfome, com-
prising about 210,000 15-mers, were used in a global
standardization process (summarized in Additional File
5 ) .B yu s i n ga l lt h e1 5 - m e r si nt h ep r o t e o m ef o rs t a n -
dardization, the statistical processes are brought into
line with the biological process where an engulfed for-
eign organism would be digested and the peptides pre-
sented would be the entire repertoire of the organism.
Furthermore, the construction of normally distributed
populations provides a means of rigorous and meaning-
ful statistical screening and selection processes from
normal Gaussian distributions (Figure 2).
A second distribution anomaly is shown in Figure 2.
N o to n l yd o e st h eb i n d i n ga f f i n i t yv a r ya c r o s sd i f f e r e n t
MHC alleles as described above, it also varies between
proteins in a proteome, giving rise to distributions like
that seen in Figure 2. This clearly demonstrates why any
organism-level conclusions about binding affinity cannot
be made based on measurements made on peptides
in isolation and should preferably not be made on
Table 2 Characteristics of the surface and secreted
proteome of Staphylococcus aureus COL
Total Proteins with TMH with TMH and SP Secreted
2,615 649 69 186
MHC-I 9-mers Avg ln(ic50) of group Total
inside 48,222 9.3 238,320
membrane 51,643 8.4
outside 138,455 9.3
MHC-II 15-mers Avg ln(ic50) of group Total
inside 40,422 6.4 210,466
membrane 38,698 4.6
outside 131,346 6.6
Total proteins and protein topology and MHC binding characteristics to
different protein domains of Staph aureus COL surface and secreted proteins.
Peptides within transmembrane domains to have a significantly higher
binding affinity to both MHC-I and MHC-II. The ln(ic50) means shown are for
peptides in the dataset for which both their N-terminus and C-terminus in the
predicted transmembrane domain. All means were different from one another
by ANOVA p < .0001. TMH = transmembrane helix; SP = signal peptide.
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based on standardized ln(ic50) ranks all peptides and
produces a ranking of affinities of all peptides in a pro-
teome against all other peptides in that proteome. This
is the situation that would arise as an infectious organ-
ism is digested in an antigen presenting cell.
Correlations between MHC-I and MHC-II
By examining the plots of many different proteins with dif-
ferent types of data portrayal we observed that, despite
individual 15-mer peptides showing widely different pre-
dicted binding affinities for the different MHC supertypes,
there was a tendency for high binding for all supertypes to
locate in certain regions of molecules and low binding in
other regions. This can be seen by undulations in the aver-
aged mean affinities across a protein sequence. Not only
was this the case among MHC-II supertypes, but was also
seen with the overall means of all MHC-I and MHC-II
supertypes (Figure 3; Table 4). After examining many dif-
ferent proteins individually it emerged that each protein
has a characteristic undulation pattern regardless of the
s u p e r t y p eo rM H C .C o m p u t e do na na f f i n i t yb a s i st h e
variations are very large with the mean affinity varying
over a thousand-fold for peptides from different regions
within a protein molecule. This long-range variation is
superimposed on a large peptide to peptide variation
within the protein.
It also became apparent that, despite the large differ-
ences in affinities between peptides, for a particular pep-
tide some of the ic50 values were highly correlated
across MHC alleles. The Pearson correlation coefficients
for the top ten and bottom ten pairwise comparisons
a r es h o w ni nT a b l e4 .F o rM H C - I Ia l lo ft h ep a i r w i s e
correlations are statistically significant and positive,
though of varying magnitude. For MHC-I there is a sub-
set that is positively correlated, another that is negatively
correlated and a third group of non-correlated alleles.
Windowing of High Affinity Binding
The positive correlations among MHC alleles and the
other statistical characteristics led us to experiment with
methods of computing binding metrics that encompassed
a population of heterozygotic combinations; effectively a
population phenotype.
Table 3 MHC-II binding affinity of heterozygous and homozygous pairs
S1 S2 10%tile S1 10%tile S2 10%tile Average 10%tile min of pair
Top Ten DRB1_0101 DRB1_0101 0.54 0.54 0.54 0.54
DRB1_0301 DRB1_0101 3.81 0.54 2.175 0.54
DRB1_0401 DRB1_0101 1.95 0.54 1.245 0.54
DRB1_0404 DRB1_0101 1.63 0.54 1.085 0.54
DRB1_0405 DRB1_0101 1.92 0.54 1.23 0.54
DRB1_0701 DRB1_0101 0.62 0.54 0.58 0.54
DRB1_0802 DRB1_0101 4.48 0.54 2.51 0.54
DRB1_0901 DRB1_0101 2.64 0.54 1.59 0.54
DRB1_1101 DRB1_0101 2.35 0.54 1.445 0.54
DRB1_1302 DRB1_0101 4.62 0.54 2.58 0.54
Bottom Ten DRB1_0301 DRB1_0301 3.81 3.81 3.81 3.81
DRB1_0802 DRB1_0301 4.48 3.81 4.145 3.81
DRB1_1302 DRB1_0301 4.62 3.81 4.215 3.81
DRB3_0101 DRB1_0301 5.74 3.81 4.775 3.81
DRB1_0802 DRB1_0802 4.48 4.48 4.48 4.48
DRB1_1302 DRB1_0802 4.62 4.48 4.55 4.48
DRB3_0101 DRB1_0802 5.74 4.48 5.11 4.48
DRB1_1302 DRB1_1302 4.62 4.62 4.62 4.62
DRB3_0101 DRB1_1302 5.74 4.62 5.18 4.62
DRB3_0101 DRB3_0101 5.74 5.74 5.74 5.74
Mean 2.92 2.37 2.64 1.88
Std Dev 1.47 1.41 1.07 1.08
Ten percentile MHC-II binding affinity statistics for 105 different heterozygous and homozygous supertype combinations for 15-mer peptides from the surface
proteome of Staphylococcus aureus COL. The results were obtained using 14 MHC-II supertypes for which training sets were available to train the NN. The
surface proteome is defined as proteins that are predicted to have one or more transmembrane helices and are therefore expected to be inserted into the cell
membrane. Top and bottom ten pairs are shown in this summary table; complete data set in Additional File 6.
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peptides are irrelevant; it is more useful to calculate a
running average of high affinities in a way that captures
the undulations in binding affinity across a protein
sequence, while also capturing the population pheno-
type. Based on these concepts we developed a system to
compute an average of standardized affinities for the
permuted pairs for all supertypes within an adjustable
(filtering) window. The window is defined as a stretch of
contiguous amino acids positions over which averaging
was carried out. Various windows (filtering stringencies)
were tested, but the most useful smoothing was
achieved with a window of ± half the size of the binding
pocket (± 4 amino acids) as shown in Figure 4.
For MHC-II this is reasonably simple to envisage, as
the ends of the pocket are open and peptides longer
than 15 amino acids could undergo rapid association:
dissociation “jiggling” until the highest binding config-
uration is found. In practice, the range of affinity con-
s t a n t si nap o o lo fp e p t i d e sm a yb ea sm u c ha s1 0 0 0
fold so that higher affinity peptides will very rapidly
occupy the MHC binding site and remain bound in
place. For MHC-I, with closed ends on the binding
pocket, the possibilities are more limited.
Another factor, which has not been included in the
predictions at this point, is the effect of the differential
proteolysis that will contribute to the variable lengths of
peptide with a possibility to interact with a binding
pocket. Several tests of the potential impact of proteaso-
mal cleavage were carried out with the webserver
NetChop 3.1 at CBS on sample protein sets (not
shown). From those experiments it appears that peptides
are very likely to be cut into pieces shorter than 9
amino acids, so that the MHC-I presentation of a pep-
tide is the result of interception and capture by the
MHC binding reaction during proteolytic cleavage. The
patterns of proteolytic cleavage of proteins by lysozomal
enzymes suggest that they would be equally aggressive
and that peptide processing for MHC-II presentation
would be expected to be comparable.
Permuting Windows for the Population
The permuted minima within the window described
above (and shown in Figure 4) are averaged to arrive at
a single number for all MHC-I allelic combinations and
another for all MHC-II combinations for each particular
amino acid position. Through experimentation we found
that this process produced metrics whose undulations
tracked the visually obvious patterns of MHC binding in
proteins (as seen in Figure 3). As the numbers were
drawn from a standardized dataset the resulting sample
were also normally distributed albeit at a distance (nega-
tive) from the population mean as a whole. Thus, statis-
tical thresholds could be applied to these metrics that
were based on normal populations. Each allelic combi-
nation was given an equal weight. This is a generalizable
concept; it is also possible to compute the predicted
population phenotype for various subpopulations using
appropriate weighting for genetic frequencies. The win-
dowing operation is not dependent on standardized
populations and the actual ln(ic50) can be used as well
to compute a running average of binding affinity for any
single allele.
The output of these computational processes was tabu-
lated in a master database for the organism (Figure 1,
Figure 2 Example of the global standardization process.T h e
global standardization process using DRB*0101 15-mers of the
combined secretome and surfome from NC_002951 Staphylococcus
aureus COL (289,760 peptides). The highlighted area shows the
peptides with an N-terminal amino acid predicted to be in a
membrane that is shifted from the mean in the original data but is
coincident with the mean after standardization. Lower panel.
Average lnN(ic50) of DRB*0101 15-mers done on a protein basis. In
this case the histogram bars are the number of proteins with the
indicated ln(ic50). The non-normal distribution is caused by proteins
with transmembrane domains with higher binding affinity.
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Page 9 of 21Step 13). Selected coincident epitope groups compris-
ing regions of proteins where peptides met three cri-
teria were determined. In these both binding threshold
for MHC and the B-cell epitope probability threshold
were in the 10 percentile range and the run of amino
acids in the predicted BEPI peptide was ≥4a m i n o
acids. Selection of the 10th percentile in two character-
istics in normally distributed variables on a probability
basis should be a product of two probabilities or about
a 1% coincidence where MHC binding regions over-
lapped either partially or completely with predicted
B-epitope regions.
Graphical Display
Figure 5 shows an annotated example of the graphical
output from the system we have described above.
Examples of Retrospective Comparisons
AntiJen multi species benchmark dataset
A summary table of our findings on the AntiJen dataset
and representative examples of graphical output for a
cross section of these proteins is provided in Additional
File 2, Table S2b and Additional File 2, Figure S2c.
The AntiJen data set comprises proteins from viruses,
bacteria, protozoa, mammals, plants, and a number of
other sources. Some are surface proteins. B-cell epitopes
were found to be located predominantly in the external
surface loops, and to a lesser degree in the cytoplasm. As
with Staph. aureus, we observed CEGs in all types of pro-
teins. A large percentage (>20%) of B-cell epitopes were
affiliated (i.e. overlapping or with their borders within 3
amino acids) with one or more MHC-I or MHC-II high
affinity binding peptides. Over 78% of MHC-I high affi-
nity binding peptides were affiliated with one or more B-
cell epitopes, as were >95% of MHC-II binding domains.
MHC-I and MHC-II high affinity binding domains
tended to be affiliated with each other.
Predicted epitopes were more prevalent in membrane
associated proteins. Many proteins, particularly those
with no transmembrane regions, had quite sparse epi-
tope distribution, nevertheless CEGs were observed in
most.
Staphylococcus aureus
We have completed analyses of B-cell epitopes, MHC-II
binding, and topology for 15 strains of Staph. aureus
(strains included are listed in Additional File 3, Table S3b).
Figure 3 Example of long range variation in mean MHC II affinity across a single protein (Thermonuclease precursor Staphylococcus
aureus COL gi 57650135). (A) DRB4*0101 and (B) DRB1*0404 have a high correlation (r = 0.6) while (C) DRB3*0101 and (D) DRB1*0901 have a
low correlation.
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predicted average minimum binding permuted for an
immunogenetically diverse heterozygous host population.
The overlaps of the various epitopes were computed using
a SOM algorithm on the centroids and dispersions of the
predicted epitope segments.
Of all predicted B-cell epitopes in Staph. aureus COL
strain, 32.13% were found to be overlapping or affiliated
with MHC-II high affinity binding peptides; 66.54% of
MHC-II binding peptides were found in affiliation with
B-cell epitopes.
Within the 15 strains of Staph. aureus we mapped a
total of 5646 CEGs. Of these, 572 were conserved across
all 15 strains. A further 364 were found in 14 of the 15
strains with usually only a single amino acid change in
the one non-conserved strain. Of the approximately
2615 proteins making up the proteome of each of the
15 strains, 98 proteins within the surfome and a further
42 proteins in the secretome were conserved across all
strains and thus contained conserved CEGs.
To evaluate our observations alongside the experimen-
tal findings of others, we identified a number of publica-
tions which provide characterization of epitopes within
five Staph. aureus proteins, documenting both predicted
B-cell epitopes and MHC binding. In Additional File 3,
Table S3a we tabulate the correlation between our
observations of CEGs and the experimental findings for
these. Much of the data pre-dates genome sequencing
projects and thus reconciling the literature with Gen-
bank is challenging. For example, in some cases peptides
were reported with amino acid numbering without con-
sideration of the signal peptide cleavage in the Genbank
proteome repository. In some cases, such as with the
staphylococcal toxins, the cleavage is substantially distal
from the starting methionine. Figure 6 shows the gra-
phical plots with the published experimental results
overlaid for two proteins; additional plots are found in
Additional File 3, Figure 3c and Figure 3d. We caution
that our plots show the permuted human population
average positions for MHC-II binding; publications may
report on experimental results derived from single HLA
or mouse MHCs. Overall there is remarkable correla-
tion. Where the most detailed fine epitope mapping is
compared to our prediction the mapped contact points
either overlap or are within 5 aa. In other cases where
mapping is not so detailed the overlapping is extensive.
We have predicted additional high affinity MHC-I and
MHC-II binding peptides not identified in the literature.
Staph. aureus Iron Regulated Determinant B (IsdB)
NC_002951.57651738
The Staph. aureus protein IsdB is a vaccine candidate;
recent papers characterize its immunological features
[50,51]. In Figure 6A predicted regions of MHC-II bind-
ing peptides and predicted B-cell epitope regions are
shown along with the positions at which point muta-
tions abrogated monoclonal antibody binding [51]. Sev-
eral features are noteworthy in the patterns seen, as
they appear commonly in proteins we have reviewed.
First, the population permuted high affinity binding
regions vary by over 2 standard deviation units. This
corresponds to over a 1000-fold range in average highest
predicted affinity binding. Regions where predicted high
affinity human MHC binding peptides are absent some-
times extend over several hundred amino acids (see also
Staph. aureus Protein A, Additional File 3, Figure S3d).
Second, regions with a paucity of high affinity MHC
binding peptides tend to have long stretches of high
probability B-cell epitopes. All the regions of monoclo-
nal antibody contacts mapped by Brown et al [51] are
located in regions of where the population would be
predicted to have high affinity MHC-II binding and the
alignment with the predicted B-cell epitopes is strong. It
should be pointed out that the 25th percentile (standar-
dized) B-cell probability threshold is twice the stringency
Table 4 Pearson correlation coefficient of ln(ic50) for
pairs of MHC-I and MHC-II alleles
MHC-I MHC-II
Top Ten HLA 1 HLA 2 r HLA 1 HLA 2 r
A*2402 A*2301 0.67 DRB4*0101 DRB1*0404 0.63
B*4403 B*4402 0.60 DRB1*0701 DRB1*0404 0.63
A*2403 A*2301 0.54 DRB1*1501 DRB1*0404 0.62
B*4403 B*4002 0.51 DRB1*0405 DRB1*0404 0.58
B*4501 B*4403 0.50 DRB1*1101 DRB1*0404 0.55
A*2403 A*2402 0.49 DRB1*1501 DRB1*0701 0.54
B*4403 B*1801 0.47 DRB5*0101 DRB1*1101 0.53
B*4501 B*4002 0.45 DRB4*0101 DRB1*1501 0.52
B*5301 B*5101 0.41 DRB5*0101 DRB1*0404 0.52
B*5301 A*2402 0.40 DRB1*1101 DRB1*0802 0.51
Bottom Ten B*5701 B*1801 -0.26 DRB3*0101 DRB1*0405 0.23
B*4501 A*2601 -0.26 DRB1*1302 DRB1*0405 0.23
B*5701 B*5401 -0.27 DRB1*1302 DRB1*1101 0.23
A*3002 A*2301 -0.28 DRB1*0901 DRB1*0301 0.22
B*4501 A*6801 -0.29 DRB3*0101 DRB1*0101 0.22
B*4403 A*3002 -0.29 DRB1*0802 DRB1*0301 0.21
B*4002 A*6801 -0.31 DRB3*0101 DRB1*1101 0.20
B*4402 A*2902 -0.31 DRB5*0101 DRB3*0101 0.20
B*4501 A*2301 -0.32 DRB1*0301 DRB1*0101 0.20
B*4403 A*2902 -0.34 DRB3*0101 DRB1*0802 0.19
B*4002 A*3002 -0.46 DRB3*0101 DRB1*0901 0.15
The Pearson correlation coefficients were computed for all allele combinations
on a random sample of 1000 15-mers (MHC-II) and 1000 9-mers (MHC-I) from
the Staphylococcus aureus COL dataset. All coefficients are significant p <
0.0001. Note that for MHC-I there are both negative and positively correlated
pairs. Some of the coefficients ~0.0 were not statistically significant in this case.
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stringency resulted in all the mapped B-cell epitopes
overlapping the predictions. The muteins produce a fine
map of discontinuous epitopes and, thus, while the B-cell
epitope prediction algorithms can only predict individual
linear peptide probabilities, it appears that they reliably
predict sub-segments of discontinuous epitopes.
Staph. aureus ABC transporter protein
NC_002951.57651892
Figure 6B shows the predicted and mapped patterns for an
ABC transporter protein. This protein was identified as a
target for clinical immunotherapeutic development based
on the work of Burnie et al [52], which documents antibo-
dies recognizing this protein in the sera of patients with
staphylococcal septicemia. Unfortunately, neither the HLA
of the patients, nor the strains of Staph. aureus were docu-
mented. There are several families of this protein and they
are present in all strains of Staph. aureus. It is predicted
by virtue of its signature motif as an ATP transporter to
be a membrane protein. We include proteins of this sort
in our surfome dataset by the use of PSORTb [53] regular
expression motif identifiers. We found the equivalent pro-
tein in all Staph. aureus c u r r e n t l ya v a i l a b l et ob ei nt w o
groups differing by two point mutations. A notable feature
of the ABC transporter is that all the mapped monoclonal
antibody binding regions are in areas predicted to have
high affinity MHC -II binding. Two caveats about the
results point to a common issue when attempting to
reconcile predictions with older studies. The mapped
regions were selected for more detailed study by Burnie
Figure 4 Demonstration of application of a binding window around a high affinity binding 15-mer. (A) Actual standardized binding
affinity N-terminus of the 15-mer begins at the point plotted. (B) peptide movement window ± 4 amino acids and (C) a binding window of ± 7
amino acids. The fine line in panels B and C is identical to that plotted in A. Semi-transparent colors yellow = extracellular, green =
transmembrane domains, and pink = intracellular predicted by Phobius. Protein: Thermonuclease precursor Staphylococcus aureus COL gi
57650135.
Bremel and Homan Immunome Research 2010, 6:8
http://www.immunome-research.com/content/6/1/8
Page 12 of 21et al [52] simply because the ELISA results for the pep-
tides were more than two standard deviations above the
mean. Hence there is not a complete panel of experimen-
tal results to compare the B-cell epitope predictions.
Clearly the experiments would also have produced a num-
ber of peptides over 1 standard deviation etc. but those
were not reported. As a result, the curators of the IEDB
have classified all other peptides in this protein as “B-cell
epitope (true negative)”.N oM H Cb i n d i n gr e s u l t sw e r e
reported.
Vaccinia
The complete proteome for VACV Western Reserve was
downloaded from Genbank and processed as described
above. We generated graphical output for all the pro-
teins and then compared the output for proteins
reported as containing immunodominant binding T-cell
epitopes [54,55]. Figure 7 shows graphical output for
I1L (GI:68275867). Additional File 7 shows comparable
output for proteins A10L (GI:68275926), A14L
(GI:68275930), and A17L (GI:68275934).
Figure 5 Annotated multidimensional overlay graphics of integrated analysis. Cryptosporidium parvum (Iowa II) hypothetical protein
cdg5_540. GI: 126649159 as an example. The portion of the overlay graphic shown contains annotations related to various cellular features and
protein topology well as the standardized predictions critical to the immunological recognition of the protein. This provides a graphical means
of visualizing a multidimensional database of related information. At various magnification levels actual peptide sequences can be visualized as
well as experimentally mapped locations for any desired HLA molecule.
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we made comparisons, were done in transgenic mice
carrying human MHC-I molecules. Thus they represent
perhaps the most clear attempt to match in silico pre-
dicted to experimental human MHC binding. Figure 7
depicts plots for protein I1L shown at two different
magnifications, to enable the visualization of peptide
sequences in the overlays. As I1L lacks transmembrane
domains the background has been left uncolored. The
colored vertical lines indicate the specific location of the
leading edge (N-terminus of a 9-mer) of predicted high
affinity peptides for the particular indicated HLA. The
colored lines extend below the permuted population
average and indicate that specific HLA shows higher
affinity binding for that peptide than does the popula-
tion as a whole. Also shown are the locations of
predicted B-cell epitopes. Notably, the peptides experi-
mentally mapped by Pasquetto et al [55] (and shown in
Figure 7 by red diamonds) are ones with predicted
binding affinity of at least 2.5 standard deviations below
the mean.
Protein I1L was reported to also contain a B-cell epi-
tope and led to the suggestion that B-cell and T-cell
epitopes being deterministically linked within the same
protein [7]. Based on the permuted population pheno-
type, we predict MHC-I and MHC-II high affinity
binding peptides, and multiple B-cell epitopes,
affiliated in three CEGs. The predictions for each HLA
used in transgenic mice by Pasquetto [55] were exam-
ined. HLA-A*0201 (Figure 7A and at higher resolution
in 7C) shows a peak of very high affinity binding for
t h ea a2 1 1 - 2 1 9p e p t i d eR L Y D Y F T R V ,ar e m a r k a b l e
3.95 deviations below the mean. The predicted initial
amino acid of this peak binding coincides exactly with
the initial arginine in the 9-mer described by Pasquetto
[55]. Interestingly, we also predict that HLA-A*0201
mice should detect binding of a similar high affinity
starting at amino acid 74. As there are ten B-cell bind-
ing regions in the top 25% probability, any one or a
combination of these could account for the linked epi-
tope response noted by Sette et al [7], however a
group of three predicted B-cell epitopes lie within
positions 198-233. Figure 7B shows the binding affi-
nities predicted for HLA-A*1101 and HLA-B*0702.
There are also high peaks of affinity, but not coinci-
dent with those of HLA-A*0201.
Discussion
Epitope Analysis System
We describe an integrated epitope analysis system which
is based on multi-dimensional and orthogonal physico-
chemical properties of sequences of amino acids using a
multilayer perceptron neural net to conduct QSAR
regression predictions for peptide affinities to 35 MHC-I
and 14 MHC-II alleles. The system allows rapid proces-
sing of single proteins, entire proteomes or subsets, as
well as multiple strains of the same organism. It allows
consideration of diversity of both microorganisms and
of host immunogenetics.
The program can be used to predict B-cell epitope
peptides and MHC-I and MHC-II binding peptides,
across strains or unique to one strain of organism, plus
spatial and topological correlation of membrane proxi-
mity. It predicts peptide affinities for HLA supertypes,
heterozygous pairs and population-permuted heterozy-
gous pairs.
The system is built on JMP® (and JMP® Genomics)
data visualization and statistical platform framework and
configured to run on a desktop computer and generate
graphical and tabular outputs. The predictions can be
expanded to other MHC molecules as more MHC train-
ing sets become available.
Table 5 Summary of analysis of Staphylococcus aureus
strains
Output for Staph aureus COL Metric
No. of Proteins in Staph aureus Col proteome 2615
No. of Surface Proteins (with Transmembrane Helices) 649
Number of Proteins with Signal Peptides 255
Sub-proteome analyzed (secreted and membrane affiliated) 835
Total B-cell epitopes > 4 aa long 14,089
Total B-cell epitopes overlapping or borders within 3 aa of a
MHC-II high affinity binding peptide
4,527
Percentage of B cell epitopes overlapping or bordering within
3 aa of a MHC-II high affinity binding peptide
32.13%
Total MHC-II high affinity binding peptides 3,230
Output for 15 Strains of Staph. aureus Metric
Proteomes of Staphylococcus aureus strains analyzed 15
Unique CEGs detected (all strains) 5646
CEGs conserved in 15/15 strains 572
Additional CEGs conserved in 14/15 strains 364
Median CEG (amino acids) 25
Minimum CEG (amino acids) 15
Maximum CEG (amino acids) 60
Proteins conserved in 15 strains with conserved CEGs (secreted
and membrane affiliated)
140
Staphylococcus aureus COL is used as an example of the properties analyzed
and observed within a strain. The data from 15 strains of Staph. aureus is
summarized in the lower half of the Table. The strains are listed in Additional
File 3, Table S3b. Epitopes conserved in 14 of 15 strains tend to have only a
single amino acid change. Epitopes characterized as B cell epitopes are within
the top 25% on a permuted population basis. Peptides characterized as a
MHC-II high affinity binding peptide are n the top 25% of binding affinities on
a permuted population basis as defined in Table 4. A CEG is a coincident
epitope group comprising a stretch of amino acids where overlapping or
adjacent B-cell epitopes as well as MHC high affinity binding peptides are
predicted.
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teins from two organisms for which epitopes have been
documented independently by many labs and have used
the ‘AntiJen’ benchmark data set. The approach we
describe has performed well for a wide variety of pro-
karyotic and eukaryotic proteins, including mammalian
cellular surface and secreted proteins. The graphical
visualization output allows perception of patterns
among predicted epitopes heretofore not recognized.
Just as GIS have permitted a more integrated view of
landscapes and have provided insights which have aided
land use and public policy decisions, the layering and
integration of all available immunological and topologi-
cal information offers new insights into organization in
the immune response.
Epitope Patterns
Having applied the integrated analysis system to the test
data sets, as well as to other proteomes, a number of
patterns emerged. Furthermore, the ability to visualize
Figure 6 Predicted and experimentally mapped epitope regions for two proteins from Staphylococcus aureus COL (NC_002951).
Graphic overlay using proteome-wide standardization of scoring metrics. Blue line is the predicted population phenotypic MHC-II binding. This is
computed as described in the methods for fourteen MHC-II alleles permuted as dizygotic combinations within a window ± 4 of the amino acid
position indicated. The orange line is the predicted B-cell epitope probability for the particular amino acid being within a B-cell epitope. Actual
computed data points are plotted along with the line that is the result of smoothing with a polynomial filter [49]. Blue horizontal bands are the
regions of high probability MHC II binding phenotype and orange horizontal bars are high probability predicted B-cell epitope regions. The
percentile probabilities used as the threshold are as described in the text and is indicated in the number within the box at the left. The red
diamonds (or groups thereof) are experimentally mapped regions of Ig binding. The experimental mapping is described in more detail in
Additional File 3 Table S3a. (A) LPXTG cell wall surface anchor protein, IsdB (GI:57651738) [51]. (B) ABC transporter, ATP-binding protein
(GI:57651892) [52].
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Page 15 of 21Figure 7 Overlay epitope maps of locus I1L (GI:68275867) from Vaccinia virus Western Reserve. (A) Vertical lines (dark red) are the N-
terminal positions of predicted high affinity binding 9-mer peptides for A*0201 predicted by neural net regression. (B) Vertical lines are the N-
terminal positions of predicted high affinity binding 9-mer peptides for A*1101 (red) and B*0702 (blue) predicted by neural net regression. (C)
Higher resolution showing fine detail of A*0201 mapping. In all three panels the experimental overlay is for MHC I 9-mer peptides mapped in
HLA A*0201/K
b transgenic mice [55]. Symbols as described in legend to Figure 6. Background is unshaded because this protein is predicted to
lack any membrane domains.
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insight into possible functional interactions.
Concordance in Binding Affinity on a Peptide Basis Across
HLAs
The initial core observation was that there is long range
coincidence of predicted high affinity MHC binding
peptides among different HLA’s in a population. When
a given protein is broken down into sequential peptides
(9-mers or 15-mers) and binding is compared against an
array of all HLAs, it is possible to map areas of higher
and lower predicted binding affinity and there is general
concordance between HLAs. Distribution is non-random
and areas of high binding can be defined on a popula-
tion basis. We observed closer positive correlation
within MHC-IIs at any given peptide than within MHC-
I. This non-random distribution and areas of high bind-
ing affinity make it possible to plot a population pheno-
type binding affinity (using the permuted pairs) and
accurately predict peptides which will serve as high affi-
nity MHC binders for the population at large, given that
all have the benefit of heterozygous alleles (e.g. in mass
vaccination). We have designed the system to permit
variation of the stringency in evaluating binding affinity,
but have focused on the top 25% binding affinity.
While there is remarkable general coincidence
between HLA alleles for the optimal binding positions
when viewed as a population, there are subtle - and
sometimes not so subtle - differences in highest affinity
peptide binding position of alleles when examined sin-
gly. These differences between individual HLAs point to
associations of HLA with a number of diseases, and in
particular the opportunity to construct personalized vac-
cines with knowledge of the patient’sH L A s .I ta l s oh a s
implications when isolated peptides are selected as sub-
unit vaccines for a diverse population and for the design
of clinical trials representative of HLA alleles. Reassur-
ingly, heterozygosity offers a distinct advantage in T-cell
epitope presentation, bringing new meaning to the sur-
vival of the “fittest”.
Regional Correlations Within Proteins
When the graphical plots for complete proteins are
viewed, other patterns emerge. Many predicted MHC-II
and MHC-I binding patterns show minima in the same
region. Both MHC classes appear to sample the same
“epitope structural space” on the protein, although not
necessarily at the same time or in the same location in
an antigen presenting cell.
Epitope clustering observed by others [56] appears to
take on a more systematic organization when viewed as
an integrated map. Our predictive analysis of the multi-
species benchmark dataset, and the other organisms we
have examined, lead to the conclusion that there are
three groups of immunogenic peptides/polypeptides:
a. Peptides which comprise B-cell epitopes overlap-
ping with or in close proximity (within a few amino
acids) to peptides binding with high affinity to
MHC-I or MHC-II molecules, which we have called
CEGs;
b. Those containing B-cell epitopes only;
c. Peptides which bind to MHC-I or MHC-II mole-
cules, and which are not associated with B-cell
epitopes.
The first two groups of epitopes (a) and (b), compris-
ing B-cell epitopes, are found external, and to a lesser
degree internal to cell membranes. Virtually no pre-
dicted B-cell epitopes are mapped within membranes.
Group (c) comprising MHC molecules without B-cell
epitopes includes some of the highest affinity MHC
binding regions located in membranes (Table 2).
The associations between predicted MHC binding
peptides and predicted B-cell epitopes in CEGs are not
ar a n d o me v e n t .I nt h eStaph. aureus dataset approxi-
mately a third of B-cell epitopes have associated MHCs
(>20% in AntiJen proteins), and over two-thirds of
MHC high affinity binding regions have affiliated B-cell
epitopes.
B-cell epitopes without close MHC binding regions
could be components of more complex epitopes as the
result of folding or positioning in the membrane. Thus
what appear as isolated B-cell epitope sequences may
actually be physically associated with components of B-
cell epitopes in CEGs. Alternatively, they may act alone
as T-independent antigens. Staphylococcal protein A is
one example of a peptide which functions under some
circumstances as a T-independent B-cell antigen [16].
Additional File 3, Figure S3d shows the remarkable B-
cell epitope, but also the pattern of predicted MHC
binding peptides in this protein.
We have shown that there is a very significantly
higher predicted binding affinity among those MHC-II
found within membranes relative to those outside or
inside of cells. Some of the highest predicted MHC
binding affinity peptides are those located within mem-
branes. Epitopes mapped in proteins A17L and A14L in
vaccinia are examples of such peptides.
Distribution of Peptide Binding Affinity within a Population
Binding of peptides to HLA molecules is a competitive
process. The distribution of binding affinity determines
which peptides are most likely to bind. Distributions of
ln(ic50) binding affinities on a protein basis are not nor-
mally distributed across alleles (Figure 2). Some alleles
approach a normal distribution but many show a bimo-
dal distribution (i.e. peptides tend to be high binders or
low binders, rather than medium binders). This charac-
teristic makes standard statistical sampling challenging.
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some peptides are simply high affinity binders. Standar-
dization makes it possible to establish thresholding cri-
teria based on normally distributed populations and
joint-probability distributions.
Using normalized distributions it is possible to com-
pute population phenotypes which effectively “capture”
the intra-protein regional correlations among MHC
alleles. In practical terms, only high affinity matters, so
we developed a scheme for computing a running aver-
age minimum over a variable amino acid “window”
(Figure 3). In the population patterns using the whole
proteins plots (e.g. Figure 6) we have used unweighted
means, i.e. we have assumed all HLA alleles to be
equally represented in the population. It would be possi-
ble to calculate phenotypes for various sub-populations
by changing allele weighting. This might be appropriate,
for instance, if selecting a vaccine for an ethnically iso-
lated population.
B-cell Receptor Prediction Programs
B-cell predictive programs like BepiPred, and the prin-
cipal component-based analogue of this we have
developed, are likely to simply predict regions with
physicochemical characteristics that lead to surface
exposure and hence which form sites accessible for
immunoglobulin attachment as predicted first by Hopp
and Wood, and Parker [24,25]. The correlation with the
fine mapping of the discontinuous epitopes for Staph.
aureus IsdB [51] provides strong support for the con-
cept that the B-cell epitope predictors identify linear
sub-regions of discontinuous epitopes in proteins. We
can speculate how, by hypervariable region mutations
during antibody maturation, successive mutations might
give rise to new molecules binding to additional short
regions in the same vicinity and thereby lead to higher
binding affinities for the new antibody mutein. By this
concept a discontinuous epitope is a logical outcome of
stepwise mutations during the maturation process. The
reported “under performance” of B-cell epitope predic-
tors [26] may be attributable at least in part to charac-
teristics like those we map in Staph. aureus Protein A
(region aa 325 to aa 475) and IsdB (aa 460 to aa 610).
This characteristic pattern is seen frequently in pro-
teome-scale overlay comparisons.
Comparative Standards
In evaluating a new predictive analytical system, the key
question is how accurately does it predict? Which begs
the question “relative to what gold standard?” Given the
multidimensionality of the interface between host
immunogenetics and pathogen, a “gold standard” has to
be specific to the combination of HLA and peptide.
Furthermore, measurements of binding affinity which
has been derived using peptides in isolation from com-
petition from the rest of the protein/proteome are of
limited utility. In light of this we do not believe a stan-
dard four quadrant (true pos, false pos, true neg, false
neg) scoring system is achievable at present. There are
presently few examples in the literature (except perhaps
Brown et al [51]) where the mapping of B-cell and T-
cell epitopes has been done with sufficient detail to
actually fill in the scoring quadrants necessary to com-
pute an AROC. The three different types of epitope pat-
terns mentioned above further complicate any attempts
at developing a simple scoring system. Our prediction
represents the theoretical maximum at any particular
chosen statistical threshold. The higher the threshold
stringency the fewer peptides that will meet the criteria.
In practice a number of factors limit the number of
peptides which actually serve as epitopes. Timing of
expression, or expression only under certain environ-
mental conditions, is one filter [11]. A further major
determinant is the rate of proteolysis, first to make the
peptides available for binding, and secondly to degrade
them into subunits below the threshold of recognition
of MHCs. As with epitope binding, enzyme action on
the proteins of the organism as a whole is a competitive
process. Proteolytic cleavage is a critical process which
determines which peptides are available to be bound by
MHC molecules and hence displayed on cell surfaces as
potential T-cell epitopes, and when such peptides
become available or cease to be available due to further
digestion. A peptide may have a predicted high binding
affinity to an MHC protein, but if it contains a protease
cleavage site precluding binding, it may never be pre-
sented at the cell surface. This is a factor not yet inte-
grated into the analytical system we describe primarily
because the cleavage training sets one would need to
produce reliable neural net predictions for the relevant
proteases are not available.
Functional Implications of Patterns Observed
B-cell recognition gives rise to an antibody response.
MHC-peptide binding is an intermediate step to presen-
tation of MHC-peptide complexes for T cell recognition.
We can speculate on whether a CEG represents a func-
tional as well as a physical association. Given the consis-
tency of the pattern, a functional association appears
likely in which B-cell binding leads to uptake of the
adjacent, overlapping or identical peptide to yield high
affinity MHC binding peptides (via MHC-I or MHC-II),
and, once bound, the peptide-MHC complex can lead to
a productive T-cell response.
When viewed in the light of the observations of
Batista of B-cell attachment and “pinching off” of sur-
face segments during the formation of an immune
s y n a p s e[ 1 5 ] ,o n ec a ne n v i s i o nh o wt h i sp h y s i c a lp r o x i -
mity might facilitate the internalization of a peptide
with a competitive advantage as a high affinity MHC
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would be consistent with the B-cell-T-cell interaction
proposed by Lanzavecchia [6]. Similarly, preservation of
B-cell epitopes by dendritic cells [57-59] would lead to
the preservation and delivery to B-cells, not only of B-
cell epitopes but also of overlapping MHC binding
peptides.
The concept of specificity runs throughout the immu-
nology literature. Generally specificity implies an abso-
lute lock and key relationship. Rather, we see a pattern
consistent with the dynamic competition for higher affi-
nity MHC binding positions within the constraints of
each set of unique host-pathogen interactions. Con-
fronted with peptides from a different protein or differ-
ent organism, the competition among peptides for
binding to the same MHC molecules would simply be
expanded. However, as affinity may range over binding
constants of 1000 fold or more, there is a marked differ-
ence between high binders and weak binders. This is
not inconsistent with a degeneracy in the binding speci-
ficity of peptides to MHC molecules. What matters is
simply the ability of an MHC molecule to bind with
high affinity a peptide representing the microorganism
(or other immunogen) presented at that moment. The
same MHC could just as well bind a peptide from
another unrelated immunogen, not present in the same
cell at that time. Given this multi step process, the effec-
tive “specificity” of the adaptive immune response is the
product of multiple sequential binding affinities - {B-cell
epitope binding }x {MHC binding} x{T-cell receptor
b i n d i n gt oM H C - p e p t i d ec o m p l e x } .N oo n eo ft h e s e
steps needs to confer complete “specificity” but the
combination increases the uniqueness or specificity of
the antigen-immune response, essentially as a combina-
tion lock.
We do not speculate on the downstream implications
of T-cell epitope binding, but note that T-cell stimula-
tion may have both up and down-regulation effects and
both positive and negative cytokine mediated feedback
loops. Whether MHC binding regions located in CEGs
have different roles from those MHC binding regions
which are unrelated to B-cell epitopes is unknown. High
affinity MHC binding regions located in membranes
may be hidden until internalized and released by proteo-
lysis, as proposed by Benacerraf [3]. This could occur
through internalization of whole organisms or when
such peptide fragments are “towed along” by internaliza-
tion of adjacent tethered peptides.
It is of interest that we predict that a large percentage
of predicted MHC-I high affinity binding peptides are
coincident with those which bind MHC-II well. This
implies that the precise intracellular pathway, and hence
which proteolytic machinery the peptide encounters,
may allow such peptides to stimulate TCD8 or TCD4,
simultaneously or sequentially. Others have noted the
need to understand the degree of overlap in the pepti-
dome leading to stimulation of each pathway [60].
Given the apparent frequent overlap of B-cell epitopes
with MHC binding regions, we suspect the literature
contains observations on many peptide epitopes where,
depending on what the experiment was designed to
observe, function as either B-cell or T-cell epitopes has
been described. Vaughan [61], in reviewing the literature
on epitope characterization for Plasmodium, noted that
14% epitopes characterized by some workers as B-cell
epitopes are reported by others to be T-cell epitopes, a
percentage not dissimilar from that seen in the surfome
of Staph. aureus and the AntiJen dataset.
At higher resolution, the fine structure of the diverse
binding patterns of different HLAs shown (Figure 7) in
vaccinia (and observed in other proteins; unpublished
data) may shed light on the concept of immunodomi-
nance, in which immune responses by an individual are
directed to a few peptides [60]. At one level it under-
scores the utility of HLA transgenic mice as indicators
of immunodominance (binding affinity) for humans
[54], while also calling into question extrapolation of
peptide level MHC binding evaluations conducted in
murine inbred strains and raising questions about the
need to reflect immunogenetic diversity in clinical trials.
Taking a broader perspective, if each HLA shows high-
est binding to a very narrow peptide sequence in given
region of a protein (immunodominant peptide) it may
represent a risk of microbial escape mutants [60]. How-
ever, because other HLAs bind to different adjacent
peptides with high affinity, heterozygosity provides a
backstop. Viewed in an immunogenetically diverse
population, it provides a possible survival strategy in
which any one escape mutant does not threaten an
entire host population.
Overall, the predicted patterns which emerge from
mapping imply yet greater coordination and organiza-
tion of B-cell and T-cell responses that have heretofore
been recorded. We do not underestimate the gap
between prediction and experimental testing; how-
ever the ability to envision hypothetical functional
interactions is a necessary precursor to design of
experimentation.
Conclusions
We present a predictive bioinformatics model which
provides a means of rapidly analyzing whole proteins or
proteomes and predicting a large number of B-cell pep-
tide epitopes and high affinity MHC binding regions
indicative of T-cell epitopes. The model also permits
correlation of peptide epitopes with topological features.
A visualization system of graphical overlays enables
ready appreciation of the potential interplay of the
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a wide array of proteins and demonstrated its perfor-
mance with several well documented proteins.
Patterns seen in examination of a protein dataset
derived from many organisms and with Staph. aureus
and vaccinia show a consistent pattern of frequent coin-
cidence of B-cell epitopes with MHC high affinity bind-
ing regions, suggesting that the physical proximity of B-
cell epitopes to peptides with high affinity for MHC-I
and MHC-II may be the norm, and of functional signifi-
cance. This hypothesis remains to be further tested
experimentally.
T h ed a t ap r e s e n t e dh e r ef o rStaph. aureus, vaccinia,
and the proteins in the AntiJen data set are of course a
retrospective look at experimentally mapped epitopes
with a view to validation of the integrated analysis sys-
tem we have developed. We have processed a number
of other proteomes and the challenge now begins as to
how best to put the system to work as a prospective
tool to support vaccine and antibody design and to pro-
vide better understanding of the immune response.
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